NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
Back to search
Official data from USPTO
BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
02/07/2023
Trademark type
Combined
Nice classes
42
Filing date
04/19/2022
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
02/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/18/2022
First use in commerce
04/18/2022
Drawing code
3
Owner type
99
Owner location
Minneapolis, MN
Examiner
WERT, KARL ANTHONY
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "BMT CTN". The words "BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK" appears below. An image of two intertwined semi-circles appear to the left.
Holders and representatives
Holders
N. P. (pessoa física)
Representatives
Kourtney A. Mulcahy AKERMAN LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting clinical trials for others in the field of blood and bone marrow transplants; Providing medical and scientific research information in the field of clinical trials and blood and bone marrow transplants; Providing a secured-access website that gives blood and bone marrow transplant centers the ability to keep updated on the progress of bone and marrow transplant clinical trials and research
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2022
PUBO
PUBLISHED FOR OPPOSITION
11/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2022
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/02/2022
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/02/2022
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
08/02/2022
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
08/02/2022
DOCK
ASSIGNED TO EXAMINER
07/28/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2022
NWAP
NEW APPLICATION ENTERED
04/22/2022
Continuous trademark protection
Get notified about every new filing that threatens BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.